PLCB2 and ductal breast carcinoma in situ: It is found that the negative correlation between PLC-β2 and miR-146a in primary DCIS cannot be detected in IDC, which indicates that the change of PLC-β2/miR-146a expression level in DCIS may constitute a molecular risk factor for IDC.